SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Listen now
Description
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
More Episodes
Dr. Justin Abbatemarco talks with Dr. Ellen Iacobaeus about patient characteristics, disease-modifying therapy, and disability progression in Swedish patients with late-onset MS and adult-onset MS over 2 decades.
Read the related article in Neurology.
Disclosures can be found at...
Published 04/25/24
Published 04/25/24
Dr. Jeff Ratliff talks with Dr. Chris Gibbons about the use of skin biopsies to detect phosphorylated α-synuclein in individuals with synucleinopathies such as Parkinson disease, multiple system atrophy, dementia with Lewy bodies, and pure autonomic failure.
Read the related article in JAMA.
...
Published 04/22/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
